Connection
Sarah Tevis to Chemotherapy, Adjuvant
This is a "connection" page, showing publications Sarah Tevis has written about Chemotherapy, Adjuvant.
|
|
Connection Strength |
|
 |
|
 |
|
0.303 |
|
|
|
-
Vemuru S, Huang J, Colborn K, Yoon Y, Huynh V, Leonard L, Ahrendt G, Christian N, Afghahi A, McLemore L, Sams S, Tevis S. Clinical implications of receptor conversions in breast cancer patients who have undergone neoadjuvant chemotherapy. Breast Cancer Res Treat. 2023 Jul; 200(2):247-256.
Score: 0.199
-
Tevis SE, Kohlnhofer BM, Stringfield S, Foley EF, Harms BA, Heise CP, Kennedy GD. Postoperative complications in patients with rectal cancer are associated with delays in chemotherapy that lead to worse disease-free and overall survival. Dis Colon Rectum. 2013 Dec; 56(12):1339-48.
Score: 0.103